London Centre for Aesthetic Surgery Ltd - Accounts to registrar - small 17.2

London Centre for Aesthetic Surgery Ltd - Accounts to registrar - small 17.2


IRIS Accounts Production v17.2.1.52 04553682 director 1.5.16 30.4.17 30.4.17 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure045536822016-04-30045536822017-04-30045536822016-05-012017-04-30045536822015-04-30045536822015-05-012016-04-30045536822016-04-3004553682ns15:EnglandWales2016-05-012017-04-3004553682ns14:PoundSterling2016-05-012017-04-3004553682ns10:Director12016-05-012017-04-3004553682ns10:PrivateLimitedCompanyLtd2016-05-012017-04-3004553682ns10:SmallEntities2016-05-012017-04-3004553682ns10:AuditExempt-NoAccountantsReport2016-05-012017-04-3004553682ns10:SmallCompaniesRegimeForDirectorsReport2016-05-012017-04-3004553682ns10:SmallCompaniesRegimeForAccounts2016-05-012017-04-3004553682ns10:FullAccounts2016-05-012017-04-300455368212016-05-012017-04-3004553682ns10:RegisteredOffice2016-05-012017-04-3004553682ns5:CurrentFinancialInstruments2017-04-3004553682ns5:CurrentFinancialInstruments2016-04-3004553682ns5:Non-currentFinancialInstruments2017-04-3004553682ns5:Non-currentFinancialInstruments2016-04-3004553682ns5:ShareCapital2017-04-3004553682ns5:ShareCapital2016-04-3004553682ns5:FurtherSpecificReserve1ComponentTotalEquity2017-04-3004553682ns5:FurtherSpecificReserve1ComponentTotalEquity2016-04-3004553682ns5:RetainedEarningsAccumulatedLosses2017-04-3004553682ns5:RetainedEarningsAccumulatedLosses2016-04-3004553682ns5:NetGoodwill2016-05-012017-04-3004553682ns5:IntangibleAssetsOtherThanGoodwill2016-05-012017-04-3004553682ns5:PlantMachinery2016-05-012017-04-3004553682ns5:FurnitureFittings2016-05-012017-04-3004553682ns5:NetGoodwill2016-04-3004553682ns5:NetGoodwill2017-04-3004553682ns5:NetGoodwill2016-04-3004553682ns5:LandBuildingsns5:ShortLeaseholdAssets2016-04-3004553682ns5:PlantMachinery2016-04-3004553682ns5:FurnitureFittings2016-04-3004553682ns5:LandBuildingsns5:ShortLeaseholdAssets2016-05-012017-04-3004553682ns5:LandBuildingsns5:ShortLeaseholdAssets2017-04-3004553682ns5:PlantMachinery2017-04-3004553682ns5:FurnitureFittings2017-04-3004553682ns5:LandBuildingsns5:ShortLeaseholdAssets2016-04-3004553682ns5:PlantMachinery2016-04-3004553682ns5:FurnitureFittings2016-04-3004553682ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-04-3004553682ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-04-30


REGISTERED NUMBER: 04553682 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2017

for

London Centre for Aesthetic
Surgery Limited

London Centre for Aesthetic
Surgery Limited (Registered number: 04553682)






Contents of the Financial Statements
for the year ended 30 April 2017




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


London Centre for Aesthetic
Surgery Limited

Company Information
for the year ended 30 April 2017







DIRECTOR: Dr R Viel





REGISTERED OFFICE: 2nd Floor
Hygeia House
66 College Road
Harrow
Middlesex
HA1 1BE





REGISTERED NUMBER: 04553682 (England and Wales)





ACCOUNTANTS: Lawrence Grant
Chartered Accountants
and Reporting Accountants
2nd Floor
Hygeia House
66 College Road
Harrow
Middlesex
HA1 1BE

London Centre for Aesthetic
Surgery Limited (Registered number: 04553682)

Statement of Financial Position
30 April 2017

2017 2016
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 270,000 315,000
Tangible assets 5 10,844 13,911
280,844 328,911

CURRENT ASSETS
Stocks 6,500 6,500
Debtors 6 21,885 12,428
Cash at bank - 959
28,385 19,887
CREDITORS
Amounts falling due within one year 7 133,421 119,204
NET CURRENT LIABILITIES (105,036 ) (99,317 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

175,808

229,594

CREDITORS
Amounts falling due after more than one
year

8

(165,429

)

(175,531

)

PROVISIONS FOR LIABILITIES (478 ) (751 )
NET ASSETS 9,901 53,312

CAPITAL AND RESERVES
Called up share capital 2 2
Capital contribution reserve 8,271 8,777
Retained earnings 1,628 44,533
SHAREHOLDERS' FUNDS 9,901 53,312

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2017 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

London Centre for Aesthetic
Surgery Limited (Registered number: 04553682)

Statement of Financial Position - continued
30 April 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 11 August 2017 and were signed by:





Dr R Viel - Director


London Centre for Aesthetic
Surgery Limited (Registered number: 04553682)

Notes to the Financial Statements
for the year ended 30 April 2017

1. STATUTORY INFORMATION

London Centre for Aesthetic Surgery Limited is a private company, limited by shares , registered in England
and Wales. The company's registered number and registered office address can be found on the Company
Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparation of financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

This is the first year in which the financial statements have been prepared under FRS 102 1A.

Turnover
Turnover is measured at the fair value of consideration received or receivable from the sale of goods and
services.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2003, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% reducing balance
Fixtures and fittings - 20% reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and
slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the statement of financial position date.


London Centre for Aesthetic
Surgery Limited (Registered number: 04553682)

Notes to the Financial Statements - continued
for the year ended 30 April 2017

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws
that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of
the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual
arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any
contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Going concern
The financial statements have been prepared on a going concern basis which is dependent upon the company's
creditors continuing to provide the necessary facilities to enable the company to continue in operation for the
foreseeable future.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2016 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2016
and 30 April 2017 900,000
AMORTISATION
At 1 May 2016 585,000
Amortisation for year 45,000
At 30 April 2017 630,000
NET BOOK VALUE
At 30 April 2017 270,000
At 30 April 2016 315,000

London Centre for Aesthetic
Surgery Limited (Registered number: 04553682)

Notes to the Financial Statements - continued
for the year ended 30 April 2017

5. TANGIBLE FIXED ASSETS
Fixtures
Short Plant and and
leasehold machinery fittings Totals
£    £    £    £   
COST
At 1 May 2016
and 30 April 2017 6,048 101,038 88,501 195,587
DEPRECIATION
At 1 May 2016 6,048 95,348 80,280 181,676
Charge for year - 1,423 1,644 3,067
At 30 April 2017 6,048 96,771 81,924 184,743
NET BOOK VALUE
At 30 April 2017 - 4,267 6,577 10,844
At 30 April 2016 - 5,690 8,221 13,911

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Trade debtors 6,893 4,490
Other debtors 14,992 7,938
21,885 12,428

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Bank loans and overdrafts 14,951 -
Trade creditors 52,718 52,710
Taxation and social security 1,443 832
Other creditors 64,309 65,662
133,421 119,204

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2017 2016
£    £   
Other creditors 165,429 175,531

9. PENSION COMMITMENTS

The company contributes to defined contribution schemes on behalf of its director and its employees. The assets
of the schemes are held separately from those of the company in independently administered funds. The pension
costs charged for the year were £208 (2016: £Nil) and there were £77 (2016: £Nil) of outstanding contributions
payable at 30 April 2017.

London Centre for Aesthetic
Surgery Limited (Registered number: 04553682)

Notes to the Financial Statements - continued
for the year ended 30 April 2017

10. RELATED PARTY DISCLOSURES

At the balance sheet date, the director Dr R Viel had a credit balance of £20,811 (2016: £14,347) on his current
account. This was an interest free loan to the company and is included in other creditors within one year.

The bank loan included in creditors is secured by personal guarantee of the director, Dr R Viel.

Also included within other creditors is a loan of £165,429 (2016: £175,531) given from London Centre for
Aesthetic Surgery Gulf FZ-LLC, a company in which Dr M Viel is a director.

11. ULTIMATE CONTROLLING PARTY

The director Dr R Viel and his brother Dr M Viel are deemed to be the ultimate controlling parties by virtue of
their 50% shareholding each in the company.